Navigation Links
Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
Date:11/4/2008

data:

Basic:

Net income per share $0.74 $0.26 $1.66 $0.85

Weighted average shares

outstanding 14,769 14,534 14,721 14,483

Diluted:

Net income per share $0.73 $0.25 $1.63 $0.83

Weighted average shares

outstanding 15,018 14,895 14,982 14,864

Kendle International Inc.

Selected Balance Sheet and Other Information

(In thousands)

(Unaudited)

Selected Balance Sheet Information:

September 30, 2008 December 31, 2007

Cash, cash equivalents and marketable

securities (including restricted cash) $18,419 $46,356

Receivables, net of advance billings 91,909 57,148

Borrowings under revolving credit

facility 2,000 -

Convertible notes 200,000 200,000

Net Services Revenues by Geographic Region:

Three Months Ended Nine Months Ended

September 30 September 30

2008 2007 2008 2007

North America 50% 51% 47% 50%

Europe 37% 41% 41% 42%

Latin America 9% 5% 8% 5%

Asia-Pacific 4% 3% 4% 3%

Segment Information:

Three Months Ended Nine Months Ended

September 30 September 30


'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
2. Kendle to Present at the UBS Global Life Sciences Conference
3. Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
4. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
5. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
6. Kendle Appoints Patricia Williams Vice President, Commercial Operations
7. Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast
8. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
9. Kendle Leaders Adopt 10b5-1 Trading Plans
10. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
11. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, 2014 ... Country Club, 1360 Almshouse Road, Warrington, Pa. , ... solely dedicated to finding a cure for hepatitis B and ... host its annual Crystal Ball on Friday, April 11 at ...
(Date:1/14/2014)... Jan. 14, 2014 As pet owners drew up their lists ... them wrote: "Take better care of my furry companion." Nowadays there ... and top-brand carrying cases to take the little canine or feline ... feel compelled to buy some pricey toys at the pet store. ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... GPRO ) announced today that the Company will present ... Tuesday, November 18,2008 at approximately 3:10 p.m. Eastern Time. ... be accessed through a link on the investors,section of ... available for 30 days following the event., About ...
... November 14, 2008 at 9:00 a.m. Eastern ... ... Inc. (Nasdaq: ALSE ) today reports operational and,financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO ), "We are encouraged by the ...
... PharmAthene, Inc.,(NYSE Alternext US: PIP), a biodefense company ... reported,financial and operational results for the third quarter ... the third quarter of 2008, PharmAthene recognized revenues ... same period of 2007. For the nine,months ended ...
Cached Biology Technology:Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 3Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 4Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 5Pharmathene Reports Third Quarter 2008 Financial and Operational Results 2Pharmathene Reports Third Quarter 2008 Financial and Operational Results 3Pharmathene Reports Third Quarter 2008 Financial and Operational Results 4Pharmathene Reports Third Quarter 2008 Financial and Operational Results 5Pharmathene Reports Third Quarter 2008 Financial and Operational Results 6Pharmathene Reports Third Quarter 2008 Financial and Operational Results 7
(Date:7/10/2014)... cutting-edge, innovative research on Alzheimer,s disease and the ... announced the recipients of new research grant awards, ... the District of Columbia, and five foreign countries. ... latest grants, BrightFocus has now provided more than ... The research projects funded this year reflect a ...
(Date:7/10/2014)... the strong currents in the Straits of Mackinac reverse ... pipeline beneath the channel would quickly contaminate shorelines miles ... a new University of Michigan study commissioned by the ... the study and accompanying animations, oil from a hypothetical ... 12 hours and Bois Blanc Island after two days. ...
(Date:7/10/2014)... NY (July 10, 2014) Columbia University Medical Center ... gene therapies for patients with retinitis pigmentosa (RP), a ... of its kind, takes advantage of induced pluripotent stem ... cells, which are then used as a patient-specific model ... approach, researchers led by Stephen H. Tsang, MD, PhD, ...
Breaking Biology News(10 mins):BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 3Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 2Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 3Patient-specific stem cells and personalized gene therapy 2Patient-specific stem cells and personalized gene therapy 3
... Geologists have a new tool to study how earthquakes change ... into how earthquake faults behave. In this week,s issue ... from the United States, Mexico and China reports the most ... from the magnitude 7.2 event that struck near Mexicali, Mexico, ...
... Researchers at Northwestern University have developed a new ... providing an alternative that is more flexible and ... describing the results, "Low-Pressure Foaming: A Novel Method ... Engineering," was featured in the February issue of ...
... hosts a panel discussion and open public forum about ... for Biosecurity (NSABB), which advises the U.S. Department of ... journals that they redact key information from unpublished manuscripts ... both good and bad purposes. The research in ...
Cached Biology News:3-D laser map shows earthquake zone before and after 23-D laser map shows earthquake zone before and after 3Researchers develop new method for creating tissue engineering scaffolds 2Georgetown hosts forum to discuss government request of journals to redact scientific data 2
... 20 years of expertise in the field ... offers the most powerful systems on the ... 40 000 in-microplate tests requiring incubation and ... different modules (such as worktable shaker incubators, ...
... or Isolated Sequence) siRNA Test System is ... evaluation of a potential of any DNA ... for RNA interference (RNAi). Current computer-based RNAi ... the probability of selected sequence to be ...
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
Glycerol-based mounting medium for immunofluorescence microscopy. Formulated to retard photobleaching of fluorochromes such as fluorescein and rhodamine. Product can also be used as a diluent for fl...
Biology Products: